From 29 April, figures for deaths include all cases where there is a positive confirmed test for COVID-19. The figures include deaths with laboratory-confirmed COVID-19 in all settings, not just those in hospital, and this provides us with a single figure on an equivalent basis for the whole of the United Kingdom.<\/p>
These UK figures are compiled from validated data provided by each of the four nations of the UK. Figures from Health Protection Scotland, Public Health Wales and the Public Health Agency (Northern Ireland) have always included tested cases outside hospital. Figures for England from 29 April onwards are provided by Public Health England and draw together several different data sources, including data from NHS England and NHS Improvement, to produce this broader measure.<\/p>
This approach allows us to compile deaths data on a daily basis using up-to-date figures across all settings.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4380", "label" : {"_value" : "Biography information for Jo Churchill"} } , "answeringMemberConstituency" : {"_value" : "Bury St Edmunds"} , "answeringMemberPrinted" : {"_value" : "Jo Churchill"} , "dateOfAnswer" : {"_value" : "2020-05-12", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1190814/answer/previousversion/18670", "answeringMember" : "http://data.parliament.uk/members/1481", "answeringMemberConstituency" : {"_value" : "Mid Bedfordshire"} , "answeringMemberPrinted" : {"_value" : "Ms Nadine Dorries"} } , "questionFirstAnswered" : [{"_value" : "2020-05-12T10:10:55.527Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2020-04-27", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Coronavirus: Death"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, by what date he plans to publish on a daily basis non-hospital deaths with covid-19.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/394", "label" : {"_value" : "Biography information for Mr Clive Betts"} } , "tablingMemberConstituency" : {"_value" : "Sheffield South East"} , "tablingMemberPrinted" : [{"_value" : "Mr Clive Betts"} ], "uin" : "40507"} , {"_about" : "http://data.parliament.uk/resources/1045911", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1045911/answer", "answerText" : {"_value" : "
A table showing the number of cases found eligible for NHS Continuing Healthcare (CHC) during the years from 2013-14 to 2017-18 is attached. The table refers to the clinical commissioning groups (CCGs) at that time; the total is for both standard and fast track NHS CHC.<\/p>
<\/p>
Tables showing CCG total NHS CHC expenditure by year, 2013-14 to 2017-18 is attached. Due to different number of weeks paid for in a care package, it is not possible to calculate an average package cost. Activity and cost data cannot therefore be used to approximate cost per person.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4008", "label" : {"_value" : "Biography information for Dame Caroline Dinenage"} } , "answeringMemberConstituency" : {"_value" : "Gosport"} , "answeringMemberPrinted" : {"_value" : "Caroline Dinenage"} , "attachment" : [{"_about" : "http://data.parliament.uk/resources/1045911/answer/attachment/1", "fileName" : {"_value" : "PQ211100 Annex B cost of CHC by CCG.xlsx"} , "title" : "PQ211100 attached table"} , {"_about" : "http://data.parliament.uk/resources/1045911/answer/attachment/2", "fileName" : {"_value" : "PQ211100 Annex A Number eligible by CCG format.xlsx"} , "title" : "PQ211100 attached table"} ], "dateOfAnswer" : {"_value" : "2019-01-28", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-01-28T14:37:07.313Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-01-22", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Continuing Care"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, how many people received continuing health care in each Care Commission Group; and the cost of that care in each of the last five years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/394", "label" : {"_value" : "Biography information for Mr Clive Betts"} } , "tablingMemberConstituency" : {"_value" : "Sheffield South East"} , "tablingMemberPrinted" : [{"_value" : "Mr Clive Betts"} ], "uin" : "211100"} , {"_about" : "http://data.parliament.uk/resources/1082575", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1082575/answer", "answerText" : {"_value" : "
Since 2015, the National Health Service contribution to the Better Care Fund (BCF) has included funding to support the implementation of the Care Act 2014, including £130 million which has been made available each year for Carers\u2019 Breaks via the NHS clinical commissioning groups (CCG) minimum contribution to the BCF.<\/p>
Locally agreed between local authorities (LAs) and CCGs, joint BCF plans set out the level of resource that will be dedicated to carer-specific support, including carers\u2019 breaks, and identify how the chosen methods for supporting carers will help to meet key outcomes. These BCF plans are agreed locally at Health and Wellbeing Board level as part of the BCF Assurance process, and funding is released under the premise that the requirements and conditions of the Fund are met. The local level allocation data is not readily available at a national level.<\/p>
We recognise the importance of carers being able to take a break from their caring role. Through the Carers Action Plan, we have committed to promoting best practice for LAs, service providers and commissioners on carer breaks and respite care. In doing so this will support them to help carers to take a break by highlighting best practice and provide advice and information for carers seeking respite breaks.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4008", "label" : {"_value" : "Biography information for Dame Caroline Dinenage"} } , "answeringMemberConstituency" : {"_value" : "Gosport"} , "answeringMemberPrinted" : {"_value" : "Caroline Dinenage"} , "dateOfAnswer" : {"_value" : "2019-03-11", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-03-11T17:10:29.497Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-03-06", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Respite Care"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, how much funding allocated to councils for respite care has been accessed to date; and what steps his Department is taking to encourage carers to make use of that support.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/394", "label" : {"_value" : "Biography information for Mr Clive Betts"} } , "tablingMemberConstituency" : {"_value" : "Sheffield South East"} , "tablingMemberPrinted" : [{"_value" : "Mr Clive Betts"} ], "uin" : "229090"} , {"_about" : "http://data.parliament.uk/resources/943001", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/943001/answer", "answerText" : {"_value" : "
Information on how much money clinical commissioning groups have spent on obtaining transparency orders is not collected centrally.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"} } , "answeringMemberConstituency" : {"_value" : "Winchester"} , "answeringMemberPrinted" : {"_value" : "Steve Brine"} , "dateOfAnswer" : {"_value" : "2018-07-23", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-07-23T15:13:03.547Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-07-17", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Clinical Commissioning Groups: Disclosure of Information"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, how much money his Department spent from the public purse on Care Commissioning Groups obtaining transparency orders in each of the last three years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/394", "label" : {"_value" : "Biography information for Mr Clive Betts"} } , "tablingMemberConstituency" : {"_value" : "Sheffield South East"} , "tablingMemberPrinted" : [{"_value" : "Mr Clive Betts"} ], "uin" : "164864"} , {"_about" : "http://data.parliament.uk/resources/1175548", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1175548/answer", "answerText" : {"_value" : "
The following patient groups are currently involved across the programme of task and finish groups. The National Institute for Health and Care Excellence (NICE) has advised that it continues to seek further members for the task and finish groups, and a full list of members is still to be finalised.<\/p>
- Alzheimer's Research UK;<\/p>
- Breast Cancer Now;<\/p>
- Cancer52;<\/p>
- Cystic Fibrosis Trust ;<\/p>
- Diabetes UK;<\/p>
- Genetic Alliance UK;<\/p>
- Leukaemia CARE;<\/p>
- Multiple Sclerosis Society;<\/p>
- Muscular Dystrophy UK;<\/p>
- Myeloma UK;<\/p>
- Neuroendocrine Cancer UK;<\/p>
- Prostate cancer UK; and<\/p>
- Sarcoma UK.<\/p>
<\/p>
In recruiting patient organisations to the NICE methods review task and finish groups, patients on the methods working group were asked to nominate representatives with a range of experience. Additional representatives were nominated by NICE where particular expertise or input was required. The organisations involved in the task and finish groups cover a broad spectrum of disease areas including cancer, non-cancer and rare diseases. <\/strong><\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4380", "label" : {"_value" : "Biography information for Jo Churchill"}
}
, "answeringMemberConstituency" : {"_value" : "Bury St Edmunds"}
, "answeringMemberPrinted" : {"_value" : "Jo Churchill"}
, "dateOfAnswer" : {"_value" : "2020-02-06", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "11443"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2020-02-06T17:20:14.623Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2020-02-03", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "National Institute for Health and Care Excellence"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, how patient organisations were recruited to the 11 NICE methods review task and finish groups.", "registeredInterest" : {"_value" : "true", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/394", "label" : {"_value" : "Biography information for Mr Clive Betts"}
}
, "tablingMemberConstituency" : {"_value" : "Sheffield South East"}
, "tablingMemberPrinted" : [{"_value" : "Mr Clive Betts"}
], "uin" : "11444"}
, {"_about" : "http://data.parliament.uk/resources/1135184", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1135184/answer", "answerText" : {"_value" : " During 2019, the National Health Service will begin to offer whole genome sequencing (WGS) as part of clinical care for:<\/p> - Seriously ill children likely to have a rare genetic disorder;<\/p> - People with one of 21 rare conditions where current evidence supports early adoption of WGS as a diagnostic test; and<\/p> - People with specific types of cancer for which there is likely to be the greatest patient benefit from using WGS \u2013 children with cancer, sarcoma and acute myeloid leukaemia.<\/p> <\/p> WGS will only replace existing diagnostic tests once the testing is demonstrated to be clinically safe to replace existing diagnostic testing. Initially, existing diagnostic testing will continue to be performed alongside WGS testing where clinically appropriate. This will continue until WGS is able to fully support clinical decision making within clinically appropriate timescales.<\/p> Current testing for blood cancers includes a number of diagnostic tests, the current expectation is that WGS will not be used to replace tests that require very fast turnaround times (under 24 hours) or high sensitivity.<\/p> WGS and non-WGS testing that will be available as part of clinical care is outlined in the National Genomic Test Directory at the following link:<\/p> <\/p>